Anaphylactoid reactions and nephrotic syndrome - A considerable risk during factor IX treatment in patients with haemophilia B and inhibitors: A report on the outcome in two brothers

Haemophilia

Volumn 4, Issue 6, 1998, Pages 854-859

  Tengborn, L ^a,b   Hansson, S ^b   Fasth, A ^b   Lubeck P O ^c   Berg, A ^c   Ljung, R ^d  

^a Department of Internal Medicine   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaphylactoid reactions; Haemophilia B; Inhibitors of factor IX; Nephrotic syndrome

Indexed keywords

BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CORTICOSTEROID; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANAPHYLAXIS; ARTICLE; BLEEDING; CASE REPORT; CHILD; DRUG MEGADOSE; GENE DELETION; HEMOPHILIA B; HUMAN; IMMUNOLOGICAL TOLERANCE; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTIC SYNDROME; NEWBORN; PRIORITY JOURNAL; PROPHYLAXIS; RISK; TREATMENT OUTCOME;

ANAPHYLAXIS; ANTIBODIES; CHILD; FACTOR IX; HEMOPHILIA B; HUMANS; MALE; NEPHROTIC SYNDROME;

EID: 0031743696     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.00190.x     Document Type: Article

References (13)

1. Warrier I, Ewenstein BM, Koerper MA, et al. Factor IX inhibitors and anaphylaxis in haemophilia B. Haemophilia 1996; 2: 259-61.
2. Lenk H, Bierbach U, Schule R. Inhibitor to factor IX and nephrotic syndrome in the course of immune tolerance treatment. Haemophilia 1996; 2: 104 (Suppl. 1).
3. Pollmann H. A haemophilia B patient with complete factor IX gene deletion and a high titer antibody against FIX. Haemophilia 1996; 2: 72 (Suppl. 1).
4. Ewenstein BM, Takemoto C, Warrier I, et al. Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood 1997; 89: 1115-16.
5. Giannelli F, Green P, Sommer S, et al. Haemophilia B (sixth edn): a database of point mutations and short additions and deletions. Nucl Acids Res 1996; 24: 103-18.
6. Mauser-Bunschoten EP, Roosendaal G, Bruin M, van Dijken PJ. Disappearance of factor VIII antibodies upon frequnt administration of factor VIII. Folia Haematol 1990; 117: 533-7.
7. Tengborn L, Berntorp E. Continuous infusion of factor IX concentrate to induce immune tolerance in two patients with haemophilia B. Haemophilia 1998; 4: 56-9.
8. Nilsson IM, Berntorp E, Zettervall O. Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies. Proc Natl Acad Sci USA 1986; 83: 9169-73.
9. Warrier I, Ewenstein B, Koerper M, et al. Factor IX inhibitors and anaphylaxis in hemophilia B. J Ped Hematol/Oncol 1997; 19: 23-7.
10. Thompson AR. Molecular biology of the haemophilias. Prog Hemostas Thromb 1991; 10: 175-214.
11. Green PM, Montandon AJ, Bentley DR, Giannelli F. Genetics and molecular biology of haemophilias A and B. Blood Coagulation Fibrinolysis 1991; 2: 539-65.
12. Ljung R. Gene mutations and inhibitor formation in patients with haemophilia B. Acta Haematol 1995; 94: 49-52.
13. Wadelius C, Blombäck M, Pettersson U. Molecular studies of hemophilia B in Sweden: identification of patients with total deletion of the factor IX gene and without inhibitory antibodies. Hum Genet 1988; 81: 13-17.